Search
for
Sort by
Research 331–360 of 657
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Comparison of Platelet-Rich Plasma Therapy Versus Intralesional Triamcinolone Acetonide in the Treatment of Alopecia Areata: A Single-Blinded, Randomised Controlled Trial
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- The Transgender: Endocrinological Assessment
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Systemic Lupus Erythematosus
- Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Embolic Stroke as the Initial Manifestation of Systemic Lupus Erythematosus
- DELIRIUM WITHOUT FOCAL SIGNS RELATED TO A THALAMIC STROKE
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- A narrative review of SARS-CoV-2 variants and long COVID
- Injectable Dual‐Crosslinked Poly(oligo(Ethylene Glycol) Methacrylate) Hydrogels Inspired by Mussel Adhesion for Cutaneous Wound Healing and Functional Tissue Regeneration
- POS1510-HPR NUTRITIONAL STATUS AND DIETARY INTAKE ASSESSMENT IN PREGNANT WOMEN WITH RHEUMATIC DISEASES
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata